. Autopsies on cases with a history of adenocarcinoma of the upper rectum indicated that hematogenous metastases developed first in the liver after seeding via the portal venous system; next, lung metastases were generated mainly by the liver metastases and next, arterial metastases were generated mainly by the lung metastases. In histologically similar cancers of the lower rectum, hematogenous metastases developed first in the lungs following seeding via the systemic veins and next, arterial metastases were generated mainly from the lung lesions. However, the patterns of arterial metastases seen in the two groups were different (Weiss et al., 1981) , and it was considered that one underlying cause of this difference was associated with the metastatic growth of the first group in the liver, prior to dissemination to the lungs.
were independently variable in both direction and amount. In addition to site-associated variations, differences in lectin expression were also detected in the liver and lungs, between cells in spontaneous metastases and cells in colonies generated by direct injection of cancer cells into the bloodstream. The results demonstrate quantitative, as distinct from qualitative, differences developing in cancer cell populations after delivery of cells to different target organs. The differences between liver and lung metastases are in accord with analogous site-associated differences in metastatic patterns produced by colon carcinoma cells in mice and in humans.
Metastasis of metastases constitutes an important aspect of disseminative patterns in human colorectal carcinoma (Weiss, 1985a; Weiss et al., 1986) . Autopsies on cases with a history of adenocarcinoma of the upper rectum indicated that hematogenous metastases developed first in the liver after seeding via the portal venous system; next, lung metastases were generated mainly by the liver metastases and next, arterial metastases were generated mainly by the lung metastases. In histologically similar cancers of the lower rectum, hematogenous metastases developed first in the lungs following seeding via the systemic veins and next, arterial metastases were generated mainly from the lung lesions. However, the patterns of arterial metastases seen in the two groups were different (Weiss et al., 1981) , and it was considered that one underlying cause of this difference was associated with the metastatic growth of the first group in the liver, prior to dissemination to the lungs.
In accord with the human autopsy data, the patterns of metastasis and organ colonisation in mice were also different following intravascular injection of colon-26 (Co26) carcinoma cells which had previously been grown in the liver, lungs or liver-then-lungs (Weiss & Ward, 1988) .
In (Mayhew et al., 1987) . Spleen tumours were obtained 9 days after intrasplenic injection of 103-104 cells (Mayhew et al., 1987) (Saint-Marie, 1962) . Sections were cut at 5 itm and following rehydration, endogenous lectins were identified by a modification of the ABC peroxidase method using a panel of 17 carbohydrates which were either directly biotinylated or coupled to biotinylated bovine serum albumin neoglycoproteins (Glaves et al., 1989) . The panel of neoglycoprotein (NGP) probes and their carbohydrate specificities are listed in Table I . Sites of reaction of endogenous lectins with these probes were visual- Following electronic image-reversal, pixel-intensity corresponds to peroxidase-staining intensity. As the densities of cancer cells in tumours in the different anatomic sites were similar, the pixel/cancer cell ratios were also similar (average: 249 pixels per cell). Determination of cancer cell staining intensities utilised predetermined threshold values as follows:
(1) Specific intensity thresholds Group I Neoglycoproteins As shown in Figure 1 , on the basis of visual inspection, pixel-intensities between 0 and 135 units corresponded to tissue gaps and non-stained cells, pixelintensities between 136 and 180 units corresponded to cancer cells with 'low' staining intensities, and those between 181 and 250 units corresponded to cancer cells with 'high' staining intensities. Although the selection of pixel intensity ranges were initially made on the basis of visual inspection, these ranges were subsequently used in all automatic densitometric measurements Group II Neoglycoproteins ABC-peroxidase reactions involving biotinylated -heparin, -fucoidan, -rhamnose-BSA, -lactose-BSA, -asialotransferrin (AST) and -asialocasein (ASC) yielded very high staining intensities, which in the case of heparin, rhamnose, and fucoidan were associated with dense nuclear staining in addition to cytoplasmic staining. These intensities exceeded the maximum extinction levels obtained with the other neoglycoproteins. Therefore, with these six neoglycoproteins (NGP), the incident illumination levels were increased, and the intensity thresholds after image-reversal were redefined: 0 to 75 intensity units for 'low'; 76 to 150 units for 'medium' and 151 to 250 for 'high' intensity reactions. These results were analysed separately from those obtained with the other NGPs.
(2) Non-specific intensity thresholds The intensities of non-specific reactions were determined for each site, by using non-biotinylated bovine serum albumin, in place of biotinylated neoglycoprotein-probes. These background reactions were subtracted from all intensity readings.
The areas occupied by regions of non-specific intensities were calculated by subtraction of the measured areas of 'high' and 'low' specific intensities from the total integrated intensity measurements. The areas occupied by stroma and gaps were determined by image analysis of hematoxylin and eosin-stained sections using 'erosion' techniques, and these areas were subtracted from the calculated non-specific intensity areas, to give the areas occupied by cancer cells with no detectable staining (i.e. 'non-stained'). Non-specific stromal background and tissue gaps were eliminated by interactive image analysis. Thus, in each field, the relative areas occupied by three classes of cells ('high' and 'low' intensity and 'non-staining') were determined.
(3) Specificity of neoglycoprotein-binding The carbohydrate specificities of the measured reactions were determined for representative endogenous lectin by blocking (pre-incubation) or competitive inhibition with corresponding free saccharides and/or unbiotinylated NGPs. In blocking experiments, sections were pre-incubated for 60 min with lOOngmm1l unbiotinylated neoglycoproteins or 0.1-0.25M free saccharide prior to incubation with biotinylated neoglycoproteins. In competitive inhibition experiments, sections were exposed to mixtures of biotinylated NGP and free saccarides or 100-fold excess of unbiotinylated NGP.
Results
The individual areas ( standard errors) of the three or four different levels of staining-intensities, for the 17 different probes, each used on tumours grown in five different sites, together with their statistical analysis, are not given in detail. Instead, the results are exemplified and summarised in 'pie' diagrams (Figures 2 to 6) Complex patterns of reactivities were observed with the 11 NGPs in Group I with tumours grown in five different sites. The areas occupied by 'high' and 'low' intensity-staining cancer cells were ranked and compared using Scheffe's multiple comparison test (Pollard, 1977) ; different ranks were significantly different at the 5% level. When no areas of 'high' or 'low' intensities were detectable in all sites with individual NGPs, no ranking was possible. For example, with aD-glucose, no 'high' intensity areas were detected in any of the tumour sections. However, when a tumour at any site Figures 2 and 3 , showing the levels of expression at each site of endogenous lectins with specificities for the sulfated polysaccharides, heparin and fucoidan.
Liver and lung metastases showed clear-cut differences in staining patterns with NGPs from both Groups I and II. Figure 4 shows examples of these different staining patterns where staining intensity areas are in general, greater in liver lesions than lung lesions with lactose, rhamnose and galNAc (also, but not shown in Figure 4 , with aD-Glucose, GalgalNAc, melibiose, Gal, GlcNAc and mannose). Areas were lower in liver than in lung lesions with fucoidan, ASC liver and lung metastases with AST, mannan, maltose and sialic acid probes. Overall, significant differences between liver and lung metastases were seen in 28 of 44 individual intensity-areas with NGPs in Group I, and 16 of 18 areas with NGPs from Group II. The liver and lung tumours examined here were of two types: those developing in animals with primary spleen or kidney lesions respectively, which are termed 'metastases', and those directly seeded via portal or tain-vein injections, which are termed 'colonies'. In the liver, statistically significant differences were detected between the areas of 'metastases' and 'colonies' expressing the different classes of staining-intensity. Thus, as shown in Figure 5 , there was significantly greater expression in liver colonies than metastases with heparin, fucoidan, AST, ASC and GaINAc (also, but not shown in Figure 5 , with fucose, melibiose, mannan, maltose and galactose); there was greater expression in metastases than colonies with aD-glucose and GalgalNAc. As shown in Figure 6 , significant differences were also observed between lung colonies and metastases; expression was greater in colonies with heparin, fucoidan, rhamnose and (not shown in Figure 6 ) GlcNAc and GalNAc. Conversely, expression was greater in lung metastases than colonies with AST and sialic acid. The battery of neoglycoproteins used in these experiments permits us to construct a multi-marker profile of endogenous lectin expression by cells derived from the same tumour, but growing in different anatomic sites. Blocking experiments with representative neoglycoproteins revealed complete blocking in five, and partial blocking in three cases, indicating a considerable level of specificity. As with the mirror image exogenous plant lectins more commonly used to probe for metastasis-associated parameters of cancer cell populations, it is not possible at present to ascribe specific functions to their receptors. Nevertheless, lectin-carbohydrate interactions in general have provided a useful index of alterations in glycoconjugates which may be associated with the tumourigenic and metastatic behaviour of cancer cells (Kellokompu, 1986; Raz & Lotan, 1987; Dennis & Laferte, 1987; Lang et al., 1988; Nicolson, 1988; Vavasseur et al., 1990; . The results of the present investigation support the inferences previously drawn from human autopsy data on cases with a history of colorectal carcinoma, and transplantation experiments with colon 26 tumours in mice, both of which indicated that site-associated changes in metastasis-related behaviour can occur in cancer cell populations during their growth in different organs, after their delivery to these anatomic sites. We have now shown that shifts in the profile of endogenous lectin expression also occur in cancer cell populations and that these shifts relative to the 'primary' lesions occur not only in the liver but also the lungs. The fact that the expression of individual lectins was independently variable, changing in different directions in the two sites, underscores the potential biologic significance of these alterations. Indeed, biochemical analyses have indicated that differences in endogenous lectins expressed by liver and lung metastases do occur in xenotransplants of human colonic carcinoma (Gabius & Engelhardt, 1988) .
It is of considerable interest that differences in endogenous lectin expression were also observed between 'metastases' and 'colonies' of Co26 cells in both the liver ( Figure 5 ) and the lungs (Figure 6 ). When mice are given intrasplenic injections of Co26 cells and then immediately splenectomised, tumours subsequently appear in the liver; more liver tumours develop when splenectomy is delayed (Ward & Weiss, 1988; unpublished data) . Therefore, in the present experiments some of the nominal liver 'metastases' are in fact 'colonies', whereas few if any of the 'colonies' resulting from portal vein injections are 'metastases'. In spite of the mixed origins, differences were demonstrable between the nominal liver 'metastases' and 'colonies'. In the case of the lung lesions, the origins of the 'metastases' and 'colonies' are distinct. These observations indicate that in addition to site-associated differences developing in cancer cell populations after delivery, differences also exist before delivery (Weiss, 1985b) , between circulating cancer cells resulting from spontaneous metastasis and those originating from direct intravenous injections. As the intravascular delivery phase of metastasis is similar in both cases, differences may well be due to population selection associated with intravasation/invasion by the 'primary' lesions (Hart, 1979) , followed by clonal amplification in the liver and lungs. However, regardless of underlying mechanisms, these results caution against the uncritical use of colonisation experiments, for those relating to the whole metastatic process.
In general, differences in cellular parameters which have been evaluated as potential markers to distinguish between normal and malignant cells, and between metastatic and non-metastatic cells, have usually been resolved as quantitative, rather than qualitative differences. The present studies on tumours growing in different sites are no exception, and indicate the necessity for objective quantitation of cancer cell parameters. The present approach establishes the feasibility of such quantitative discrimination among differences in multiple parameters which may be subtle and independently variable. This type of approach provides a valuable way of constructing a profile of cancer cell populations, in situ, with preservation of their topographic relationships to each other and to normal host cells.
